Research conducted on cultured trigeminal neurons suggests that migraine treatment strategies can inhibit CGRP transcription and curtail its release, while tumor necrosis factor alpha (TNF-α) may stimulate the transcription of this peptide [15]. This evidence concerns the gene TNF and migraine disorder.